Hadi Erfani, MD, MPH(@sherfani) 's Twitter Profile Photo

Just finished the Palliative Care Certificate Program. Learned soo much from it. Totally recommend to all my co-fellows in globally. Thanks to IGCS for putting this resource together.
IJGC European Network of Young Gynae Oncologists ESGO Mary Eiken, MS Keiichi Fujiwara

Just finished the Palliative Care Certificate Program. Learned soo much from it. Totally recommend to all my co-fellows in #gyncsm globally. Thanks to @IGCSociety for putting this resource together. 
@IJGConline @ENYGO_official @ESGO_society @MaryCEiken @keiichifujiwara
account_circle
Joshua Garrett Cohen(@JCohenMD) 's Twitter Profile Photo

Dr. Senguttuvan COH gyn onc fellow presenting data low grade endometrioid uterine cancers w/ TP53 mutations have worse prognosis regardless of new FIGO stage. We need new tx paradigms for these pts City of Hope | Orange County⁩ ⁦City of Hope Surgery⁩ ⁦Rosemary Noel Senguttuvan, MD, FACOG

Dr. Senguttuvan COH gyn onc fellow presenting data low grade endometrioid uterine cancers w/ TP53 mutations have worse prognosis regardless of new FIGO stage. We need new tx paradigms for these pts #SGOmtg #gyncsm ⁦@cityofhopeoc⁩ ⁦@CityofHopeSurg⁩ ⁦@RSenMD⁩
account_circle
ACS Journal Cancer(@JournalCancer) 's Twitter Profile Photo

Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study

acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

@oncoalert

Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study

acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

@oncoalert #gyncsm
account_circle
Joshua Garrett Cohen(@JCohenMD) 's Twitter Profile Photo

Great start to the 2024 ! Let's support research and education for patients impacted by the 5 gynecologic cancers, join barcode below SGO⁩ ⁦Angeles Secord⁩ ⁦Ginger J. Gardner⁩ ⁦Eric Rios-Doria, MD

Great start to the 2024 #SGOmtg! Let's support research and education for patients impacted by the 5 gynecologic cancers, join #move4her barcode below #gyncsm ⁦@SGO_org⁩ ⁦@AngelesSecord⁩ ⁦@ggardnermd⁩ ⁦@RiosDoriaMD⁩
account_circle
Nicole D. Fleming MD(@nicoleflemingmd) 's Twitter Profile Photo

Congrats to our fellow Dr Huepenbecker on her poster presentation SGO evaluating outcomes of traditional ERAS pathways in patients undergoing pelvic exenteration in Gyn cancers MD Anderson Cancer Center

Congrats to our fellow Dr Huepenbecker on her poster presentation @SGO_org evaluating outcomes of traditional ERAS pathways in patients undergoing pelvic exenteration in Gyn cancers @MDAndersonNews #SGOMtg #gyncsm #oncsurgery
account_circle
Shannon Westin, MD, MPH, FASCO(@ShannonWestin) 's Twitter Profile Photo

🤔Analysis of the GOG258 trial results in based on TCGA classifiers is intriguing...
Improvement in RFS for p53wt treated with chemoradiation as opposed to chemotherapy, however, no apparent benefit w/ radiation therapy in MMRd

🤔Analysis of the GOG258 trial results in #EndometrialCancer based on TCGA classifiers is intriguing...
Improvement in RFS for p53wt treated with chemoradiation as opposed to chemotherapy, however, no apparent benefit w/ radiation therapy in MMRd #SGOMtg #gyncsm #radonc
account_circle
Ovarcome(@ovarcome) 's Twitter Profile Photo

'When you are suffering, find that quiet space in your mind - it will give you the strength to continue Ovarcoming💙' .
#97 of CONNECT OVAR COFFEE ☕️ is a must watch - now available On Demand. Watch & Share - Let's ! ☕️ GYN Cancer | #GYNCSM
WATCH: youtu.be/1hjlPD3gX6I?fe…

account_circle
Shannon Westin, MD, MPH, FASCO(@ShannonWestin) 's Twitter Profile Photo

👏Encore presentation of LEAP-001 at - this trial compared lenvatinib/pembrolizumab to paclitaxel/carboplatin in first line advanced/recurrent

👏Encore presentation of LEAP-001 at #SGOMtg - this trial compared lenvatinib/pembrolizumab to paclitaxel/carboplatin in first line advanced/recurrent #EndometrialCancer #gyncsm
account_circle
Ovarcome(@ovarcome) 's Twitter Profile Photo

Pathbreaking Advances in Rare Ovarian Cancers by Dr. Rachel Grisham was a 💯 at ZEAL FOR TEAL! Now available On Demand on our YouTube.
Subscribe. Watch. Share! Team Ovary, Memorial Sloan Kettering Cancer Center GYN Cancer | #GYNCSM
WATCH full video: youtu.be/20_XhLVDECI?fe…

account_circle
SMarkovina(@SMarkovina2) 's Twitter Profile Photo

So incredibly proud of these presenting their cervical cancer research at . We won’t stop til no one dies from cervical cancer IamCervivor

So incredibly proud of these #womeninSTEM presenting their #gyncsm cervical cancer research at #AACR24. We won’t stop til no one dies from cervical cancer @IamCervivor
account_circle